Clinical Trials Logo

Clinical Trial Summary

The fetus may be exposed during pregnancy to nociceptive stimuli because of fetal pathology (e.g., malformation) or a diagnostic or therapeutic procedure.

To date, there is very little data and no consensus on fetal analgesia. The aim of the investigators study is to evaluate the pharmacokinetics of Sufentanil after intra amniotic injection.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02962830
Study type Interventional
Source University Hospital, Lille
Contact Véronique HOUFFLIN-DEBARGE, MD,PhD
Phone +33-3 20 44 69 08
Email veronique.debarge@chru-lille.fr
Status Recruiting
Phase Phase 2
Start date April 19, 2017
Completion date October 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04285814 - Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
Completed NCT04119349 - Influence of Prenatal Counseling in Invasive Testing N/A
Completed NCT03955588 - Replacement of Cytogenetics by aCGH in Prenatal Diagnosis
Not yet recruiting NCT05940363 - The National Program for the Improvement of Management of Fetal Congenital Heart Disease in China
Recruiting NCT03201666 - Comparison of Karyotyping, CMA and NIPT for Prenatal Diagnosing Chromosomal Anomalies N/A
Completed NCT00872703 - Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Infection? N/A
Completed NCT04265352 - Postnatal Managemant of Prenetal Cardiac Echogenic Foci in Hillel Yaffe Medical Center
Recruiting NCT06239077 - Identifai Genetics Analytic Validity Study - Compound Heterozygosity and Samples Collection N/A
Not yet recruiting NCT06081036 - Normative Brain Volume Profiles From Multicenter Fetal MRI